SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031993
Filing Date
2019-08-14
Accepted
2019-08-14 09:05:31
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-10q_20190630.htm 10-Q 2171706
2 EX-4.6 phas-ex46_30.htm EX-4.6 90401
3 EX-4.7 phas-ex47_29.htm EX-4.7 92133
4 EX-31.1 phas-ex311_8.htm EX-31.1 16767
5 EX-31.2 phas-ex312_9.htm EX-31.2 16752
6 EX-32.1 phas-ex321_7.htm EX-32.1 7581
7 EX-32.2 phas-ex322_6.htm EX-32.2 7581
  Complete submission text file 0001564590-19-031993.txt   5751937

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT phas-20190630.xml EX-101.INS 808067
9 XBRL TAXONOMY EXTENSION SCHEMA phas-20190630.xsd EX-101.SCH 41962
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phas-20190630_cal.xml EX-101.CAL 42200
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phas-20190630_def.xml EX-101.DEF 143009
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE phas-20190630_lab.xml EX-101.LAB 350933
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phas-20190630_pre.xml EX-101.PRE 254415
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 191023140
SIC: 2834 Pharmaceutical Preparations